Maravai LifeSciences Investor Relations Material
Latest events
Q3 2024
Maravai LifeSciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Maravai LifeSciences Holdings Inc
Access all reports
Maravai LifeSciences Holdings, Inc. is a life sciences company providing products for research and development of drug therapies to enable the discovery, development, manufacture and commercialization of novel vaccines, therapeutics and diagnostic tests. The company's main offerings includes innovative and cost-effective products, technologies and services to the biopharmaceutical, vaccine and other healthcare industries. From small molecule development through to cell culture process development, Maravai offers a wide range of enzyme-linked immunoassay (ELISA) reagents for diagnostics development, safety testing and commercial production. Maravai's customers include market-leading companies - to which they sell proprietary technologies that enables rapid development of drug therapies, including antibody-based therapeutics, globally. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Key slides for Maravai LifeSciences Holdings Inc
Q3 2024
Maravai LifeSciences Holdings Inc
Q4 2023
Maravai LifeSciences Holdings Inc
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
MRVI
Country
🇺🇸 United States